
Exploring Alternative Pain Management Strategies for Headaches and Migraines | AMCP Nexus 2024
New research presented at AMCP Nexus 2024 highlighted the effectiveness and cost-effectiveness of various migraine treatments, including onabotulinumtoxinA and fremanezumab, as well as the importance of migraine education programs for improving patient outcomes.
READ MORE:
Ready to impress your pharmacy colleagues with the latest drug information, industry trends, and patient care tips? Sign up today for our
References
1. Ailani J, Blumenfeld A, Ahmadyar G, et al. Long-term persistence of patients with chronic migraine switching to onabotulinumtoxinA or a different calcitonin gene-related peptide monoclonal antibody (CGRP mAb) after initial CGRP mAb treatment. Presented at: AMCP Nexus 2024; October 14-17, 2024; Las Vegas, NV. Poster G40.
2. Blumenfeld A, Ailani J, Ahmadyar G, et al. Long-term persistence of onabotulinumtoxinA vs calcitonin gene-related peptide monoclonal antibodies in new initiators with chronic migraine. Presented at: AMCP Nexus 2024; October 14-17, 2024; Las Vegas, NV. Poster G41.
3. Yang A, Xie H, Zhang Y, Chatterjee S, Ortega M, Driessen M. Comparative analysis of fremanezumab vs preventive gepants for the prevention of episodic migraine on migraine-related health care resource utilization and direct costs. Presented at: AMCP Nexus 2024; October 14-17, 2024; Las Vegas, NV. Poster G42.
4. Gokhale P, Villa-Zapata L. Cost-effectiveness analysis of Ubrogepant, Rimegepant, and zavegepant compared with each other and usual care for the acute treatment of migraine. Presented at: AMCP Nexus 2024; October 14-17, 2024; Las Vegas, NV. Poster G43.
5. Atkinson C, Wallis H, Amet M, Quinones E, Park T, Shah D, et al. Benefits of an educational migraine program on those living with migraine in the workplace: The ENLIGHTEN study. Presented at: AMCP Nexus 2024; October 14-17, 2024; Las Vegas, NV. Poster G38.
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.




















































































































































